Vuong Trieu - Net Worth and Insider Trading
Vuong Trieu Net Worth
The estimated net worth of Vuong Trieu is at least $5 Million dollars as of 2024-04-29. Vuong Trieu is the CHAIRMAN AND CEO, 10% Owner of Oncotelic Therapeutics Inc and owns about 115,272,130 shares of Oncotelic Therapeutics Inc (OTLC) stock worth over $5 Million. Details can be seen in Vuong Trieu's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Vuong Trieu has not made any transactions after 2023-06-28 and currently still holds the listed stock(s).
Transaction Summary of Vuong Trieu
Vuong Trieu Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vuong Trieu owns 3 companies in total, including Oncotelic Therapeutics Inc (OTLC) , Adhera Therapeutics Inc (ATRX) , and Sorrento Therapeutics Inc (SRNE) .
Click here to see the complete history of Vuong Trieu’s form 4 insider trades.
Insider Ownership Summary of Vuong Trieu
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTLC | Oncotelic Therapeutics Inc | 2023-06-28 | CHIEF EXECUTIVE OFFICER |
| ATRX | Adhera Therapeutics Inc | 2016-11-15 | director & Chairman of the Board |
| SRNE | Sorrento Therapeutics Inc | 2013-09-09 | director & Chief Scientific Officer |
Vuong Trieu Latest Holdings Summary
Vuong Trieu currently owns a total of 1 stock. Vuong Trieu owns 115,272,130 shares of Oncotelic Therapeutics Inc (OTLC) as of June 28, 2023, with a value of $5 Million.
Latest Holdings of Vuong Trieu
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OTLC | Oncotelic Therapeutics Inc | 2023-06-28 | 115,272,130 | 0.04 | 4,841,429 |
Holding Weightings of Vuong Trieu
Vuong Trieu Form 4 Trading Tracker
According to the SEC Form 4 filings, Vuong Trieu has made a total of 10 transactions in Oncotelic Therapeutics Inc (OTLC) over the past 5 years, including 10 buys and 0 sells. The most-recent trade in Oncotelic Therapeutics Inc is the acquisition of 500,000 shares on June 28, 2023, which cost Vuong Trieu around $15,000.
Insider Trading History of Vuong Trieu
- 1
Vuong Trieu Trading Performance
GuruFocus tracks the stock performance after each of Vuong Trieu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vuong Trieu is -4.86%. GuruFocus also compares Vuong Trieu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Vuong Trieu within 3 months outperforms 3 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Vuong Trieu's insider trading performs compared to the benchmark.
Performance of Vuong Trieu
Average Return
-27.16%
Outperforming Transactions
14%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.11 | -4.86 | -1.25 | -27.16 | -7.37 | -36.27 |
| Relative Return to S&P 500(%) | -9.33 | -8.9 | -9.9 | -49.61 | -25.72 | -47.66 |
Vuong Trieu Ownership Network
Ownership Network List of Vuong Trieu
Ownership Network Relation of Vuong Trieu
Vuong Trieu Owned Company Details
What does Oncotelic Therapeutics Inc do?
Who are the key executives at Oncotelic Therapeutics Inc?
Vuong Trieu is the CHIEF EXECUTIVE OFFICER of Oncotelic Therapeutics Inc. Other key executives at Oncotelic Therapeutics Inc include CHIEF BUSINESS OFFICER Saran Saund , CHIEF FINANCIAL OFFICER Amit B. Shah , and CHIEF TECHNOLOGY OFFICER Chulho Park .
Oncotelic Therapeutics Inc (OTLC) Insider Trades Summary
Over the past 18 months, Vuong Trieu made 6 insider transaction in Oncotelic Therapeutics Inc (OTLC) with a net purchase of 1,016,888.
In summary, during the past 3 months, insiders sold 0 shares of Oncotelic Therapeutics Inc (OTLC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oncotelic Therapeutics Inc (OTLC) were sold and 1,016,888 shares were bought by its insiders, resulting in a net purchase of 1,016,888 shares.
Oncotelic Therapeutics Inc (OTLC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncotelic Therapeutics Inc Insider Transactions
Vuong Trieu Mailing Address
Above is the net worth, insider trading, and ownership report for Vuong Trieu. You might contact Vuong Trieu via mailing address: 4003 Jim Bowie Road, Agoura Hills Ca 91301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
